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STUDY PROTOCOL Open Access
Lifestyle changes and glycemic control in
type 1 diabetes mellitus: a trial protocol
with factorial design approach
Sobiya Sawani1*, Amna Rehana Siddiqui1, Syed Iqbal Azam1, Khadija Humayun2, Asma Ahmed3, Aysha Habib4,
Sabahat Naz1, Mayera Tufail1 and Romaina Iqbal1,3
Abstract
Background: Type 1 diabetes (T1D) has been increasing globally over the past three decades. Self-monitoring of
blood glucose is a challenge in both developed as well as developing countries. Self-management guidelines
include maintaining logbooks for blood glucose, physical activity, and dietary intake that affect glycated
hemoglobin (HbA1c) and a multitude of life-threatening acute complications. Innovative, cost-effective
interventions along with beneficial lifestyle modifications can improve home-based self-monitoring of blood
glucose in T1D patients. The overall objective of this study is to evaluate the relationship between maintaining log
books for blood glucose levels, reinforcement by e-messages, and/or daily step count and changes in HbA1c.
Methods/design: A randomized controlled trial will enroll participants aged 15 years and above in four groups.
Each group of 30 participants will be working with a newly designed standard log book for documenting their
blood glucose. The first group will be entirely on routine clinical care, the second group will be on routine care and
will receive an additional e-device for recording step count (fit bit), the third group will receive routine care and
daily motivational e-messages to maintain the log book, and the fourth group along with routine care will receive
an e-device for measuring step count (fit bit) and e-messages about maintaining the log book. Patients will be
enrolled from pediatric and endocrine clinics of a tertiary care hospital in Karachi. All groups will be followed up for
a period of 6 months to evaluate outcomes. Log book data will be obtained every 3 months electronically or
during a patient’s clinic visit. HbA1c as a main outcome will be measured at baseline and will be evaluated twice
every 3 months. A baseline questionnaire will determine the socio-demographic, nutritional, and physical activity
profile of patients. Clinical information for T1D and other co-morbidities for age of onset, duration, complications,
hospitalizations, habits for managing T1D, and other lifestyle characteristics will be ascertained. Behavioral
modifications for maintaining daily log books as a routine, following e-messages alone, fit bit alone, or e-messages
plus using fit bit will be assessed for changes in HbA1c using a generalized estimated equation.
Discussion: The proposed interventions will help identify whether maintaining log books for blood glucose,
motivational e-messages, and/or daily step count will reduce HbA1c levels.
Trial registration: ClinicalTrials.gov, NCT03864991. March 6, 2019.
Keywords: Type 1 diabetes, Self-management, HbA1c, Log books, Step count
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Background
Type 1diabetes (T1D) is an autoimmune disease in
which insulin-producing beta cells in the pancreas are
destroyed by the human body pathologically, preventing
the body from being able to produce enough insulin to
adequately regulate blood glucose levels. The diagnosis
is based on clinical factors (age, lack of obesity, and in-
sulin resistance), low C-peptide levels, and insulin anti-
bodies. Substantial destruction of insulin-producing beta
cells in the pancreas of T1D patients means that rigor-
ous blood glucose monitoring for adjustment of insulin
dosage is required on a daily basis [1].
T1D occurs mostly in the pediatric and adolescent age
groups with patients presenting with a hyperglycemia
and/or diabetic ketoacidosis episode. Such episodes are
also the most common life-threatening adverse effects
following diagnosis resulting from suboptimal treatment
if insulin dosage is not adjusted and blood glucose is not
monitored on a daily basis. The incidence of T1D has
been increasing over the past three decades [2]. Manage-
ment of T1D is a big challenge in resource-constrained
low to middle income countries due to the need for daily
self-monitoring of blood glucose (SMBG) levels and
timely entry of these in a log book [3, 4]. SMBG is an in-
valuable method for monitoring glycemic status; current
guidelines recommend its use in all patients with T1D,
type 2 diabetes mellitus (T2DM), or any other forms of
diabetes (e.g., gestational diabetes) that require adminis-
tering multiple subcutaneous insulin injections [5]. A
study of children and adolescents with T1D showed that
an increased daily frequency of SMBG was significantly
associated with lower HbA1c levels (0.2% per additional
test per day) along with the added benefit of fewer acute
complications such as ketoacidosis [6]. Use of innovative
mobile phone applications and regular SMBG have been
shown to increase compliance with proposed treatment
regimens [7].
Taking an extra 1000 steps per day can help to reduce
the risk of cardiovascular events significantly in T1D pa-
tients [8]. A wireless wearable e-device accompanied by
an application (called the fit bit app) tracks step count
by recording data in a mobile phone application [9–11].
Studies conducted in Pakistan report non-adherence of
T1D patients to dietary advice (58.5%), physical activity
recommendations (42.3%), and prescribed insulin regi-
mens (88.1%), with staggering rates of complications
such as diabetic acidosis due to suboptimal treatment
[12, 13]. HbA1c levels acts as an indicator of glycemic
control and correlate with the occurrence of complica-
tions [14]. However, HbA1c levels do not indicate the
daily variability of blood glucose. The risk related to
daily fluctuation of blood glucose levels can be assessed
by a devised method [15, 16]. This study proposes to
study maintenance of log books for blood glucose levels
and whether motivational e-messages and/or using an e-
device for measuring step count, alone or together, can
potentially help reduce HbA1c levels in T1D patients. In
addition, it will explore any effect of increasing step
counts on daily blood glucose levels and reduction in
acute complications by maintenance of log books for
blood glucose.
Rationale
Adequate glycemic control along with a healthy lifestyle
are associated with improved health outcomes and lower
morbidity and premature mortality in diabetes patients.
Therapeutic insulin regimens need to be strongly regu-
lated during the adolescent period to prevent complica-
tions in T1D patients [17]. Adolescents with poor
glycemic control had greater proportions of diabetic ret-
inopathy and micro- and macro-albuminuria than pa-
tients who maintained their HbA1c levels in a strict
therapeutic range [17]. Adherence to management pro-
tocols and insulin regimens had an inverse association
with occurrence of acute complications in several studies
on T1D patients [18, 19]. Poor compliance with or no
insulin regimen were directly associated with severity of
diabetic ketoacidosis in T1D patients in Pakistan, who
needed longer hospital stays [20]. Family-centered care
empowering family members to maintain a blood glu-
cose level record sheet, insulin dosage recording, phys-
ical activity, and a meal plan resulted in significant
differences in behavior and supervision of adolescents
with T1D [21]. At the regional level management of
T1D is a big challenge as physicians tend not to adhere
to the international treatment guidelines regularly [4, 9].
Several e-devices are available to monitor physical activ-
ities and these have been studied globally for use by dia-
betic patients [6, 9–11]. Most of the studies using and e-
device for improving patient outcomes have been per-
formed on T2D patients due to its high prevalence [22–
27]. T1D patients are usually in the pediatric age bracket
and have increased chances of severe acute complica-
tions; therefore, multifaceted approaches involving pa-
tients, parents, families, doctors, and stakeholders are
required for optimal T1D management [12, 13, 17, 20,
28]. A study done in India assessed the reliability of
SMBG logs compared with glucometer memory in chil-
dren with T1D and the impact on glycemic indicators.
Children who maintained accurate records (aged 11.54 ±
4.05 years) had decreased HbA1c levels (from 10.79 ±
2.61% to 7.99 ± 0.84%) and those participants who kept
inaccurate records had decreased HbA1c levels (from
10.74 ± 2.60% to 9.01 ± 2.33% over a period of 4 months
(p < 0.002) [6]. There is a dearth of literature on testing
of basic, cost-effective interventions to improve home-
based and self-monitoring of blood glucose levels and
management of insulin regimens with added beneficial
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lifestyle modifications. Therefore, the proposed study will
record adherence to standard protocols for maintenance
of SMBG records by patients, checking HbA1c level every
three months, and maintaining an insulin dosage record
on a daily basis to determine if these lead to reduction in
acute complications in T1D patients, thereby reducing
their illness-associated mortality and morbidity.
Study purpose
The purpose of this formative research using a factorial
design is to evaluate the relationship between maintain-
ing log books for daily blood glucose, reinforcement by
e-messages, and/or daily step count using a fit bit device
and changes in HbA1c in T1D patients visiting Aga
Khan University (AKU) endocrine clinics. In addition,
episodes of acute complications will be compared in




1. To determine the effect of daily mobile phone
messages for maintenance of log books and self-
monitoring of blood glucose levels on HbA1c levels
in T1D patients in comparison to routine clinical
care
2. To determine the relationship of wearing an e-
device for daily step count with blood glucose levels
and changes in HbA1c in T1D patients in compari-
son to routine clinical care
Secondary objectives:
1. To compare the acute complications of T1D in all
groups over a period of 6 months
2. To compare the variability of daily blood glucose




A factorial design will help to study lifestyle changes for
self-management of T1D (Fig. 1). A randomized con-
trolled method will enroll patients in a predefined se-
quence, assigning them in four groups. All groups will
be working with a newly designed standard log book for
documenting records for blood sugar and routine insulin
dosage and care as provided by doctors, nurses, and nu-
tritionists. The first group will all receive routine care
follow-up, the second group will receive an additional e-
device for measuring step count (fit bit), the third group
will receive routine care and e-messages as reminders to
maintain a daily log book, and the fourth group will
receive an e-device for measuring step count (fit bit) and
e-messages about maintaining the log book, blood glu-
cose levels, and step count in addition to routine care.
All groups will be followed up overall for a period of 6
months. HbA1c as a main outcome will be measured at
least three times, at baseline, and then once every 3
months.
Study setting
The study will be conducted in pediatric and adult endo-
crinology clinics at Aga Khan University (AKU) Karachi,
where records of patients are maintained electronically
using a heath information management system (HIMS)
as well as individual medical record files. Patients under
the care of consultant endocrinologists who fulfill the in-
clusion criteria will be enrolled.
Study participants
We plan to include all T1D patients aged more than 14
years visiting pediatric and endocrine clinics of AKU.
We plan to enroll patients who have been diagnosed
with T1D at least 6 months prior to the enrollment.
Enrolment procedure
Informed consent will be obtained from patients aged 18
or more years and assent from patients aged less than 18
years with additional consent from parents.
Inclusion and exclusion criteria
Males and females diagnosed with T1D and aged more
than 14 years who present to pediatric and endocrine
clinics of AKU and have a smart phone or a family
member with a smart phone, such as parents or elder
sibling, are eligible to participate in the study. However,
patients using an “insulin pump” will be excluded. Pa-
tients with complicated health conditions such as neuro-
developmental delay and thalassemia will be excluded.
Furthermore, patients already using any kind of authen-
tic e-device for measuring step count and/or physical ac-
tivity will also be excluded from the study.
Randomization
Unique allocation numbers will be designated by the
Clinical Trail Unit (CTU) with computer-generated
block randomization, using a block size of four. Sealed
opaque identical envelopes will be received by the prin-
cipal investigator (PI) from the CTU in an order that will
be followed to enroll study participants in all four
groups. The data collector will be instructed to assign al-
located numbers to participants in sequential order as
they are enrolled. Upon opening the envelope, the group,
A, B, C, and D, will be revealed to the data collector and
items related to the appropriate group will be explained
to the study participant. Group A will be told to follow
Sawani et al. Trials          (2020) 21:346 Page 3 of 9
routine care, group B will receive an additional e-device
for measuring step count (fit bit) and the data collector
will download the associated application onto the partici-
pant’s cell phone, group C will receive routine care and e-
message reminders from the data collector to maintain a
daily log book, and group D will receive routine care as
well as an e-device for measuring step count (fit bit) to-
gether with the associated application (downloaded onto
the participant’s cell phone by the data collector) and e-
messages from the data collector as reminders to maintain
their log book, blood glucose levels, and step count.
Sample size and sampling technique
Overall, 120 patients with T1D will be randomized into
four equal groups for evaluating changes in HbA1C
using multiple measurements at multiple time points.
Thirty patients in each group will be required in order
to achieve 80% power for a two-sided level of signifi-
cance of 5%, using a standard deviation of change in
HbA1c between 1.1% and 2.3% and absolute difference
of at least 2% expected over a period of 6 months within
a group from baseline as well as when compared across
the four groups [29]. A consecutive sampling technique
Fig. 1 Flow diagram
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will be used to enroll participants visiting AKU pediatric
and endocrinology clinics and fulfilling the eligibility
criteria.
Interventions
A predesigned log book file will be provided to all pa-
tients in all groups to keep their records of daily blood
sugar measurement and insulin therapy (Fig. 2). Random
allocation of patients to one of the four groups will be
done through support from the CTU at AKU using
sealed envelopes. The first intervention group will re-
ceive an e-device for daily step count (fit bit). The other
two intervention groups will receive reminder mobile e-
messages: one will receive only mobile messages (with-
out fit bit) about maintaining the log book for blood glu-
cose and the other will receive the mobile messages for
maintaining the log book for blood glucose and for fit
bit along with an e-device for measuring step count
(Table 1). Fit bit has been shown to have high validity
and reliability [10], with the potential advantage over
other similar e-devices (accelerometers, pedometers, or
actigraphs) of increasing the sustainability of this inter-
vention given that it is cost-effective [27].
Follow-up and other procedures
An orientation meeting of endocrinology unit clinicians
and their staff will be conducted prior to initiation of the
study to obtain their cooperation for sharing their
clinics’ schedules a day prior. HbA1c levels will be la-
boratory measured at least three times, at baseline and
then once every 3 months. Every 3 months, 24-hour
dietary recall and physical activity assessments will be
performed. Patients’ routine clinic visits are at 3 months
and follow up visits will be coordinated accordingly for
mid and final data collection and 3-monthly HbA1c test-
ing. Instructions for the e-device (fit bit) will be provided
to patients in the respective groups, and its use will be
demonstrated to them. A written instruction sheet will
Fig. 2 Logbooks for groups A and C to record their daily blood sugar readings and insulin doses and for groups B and D to record daily blood
sugar readings, insulin doses, and step count
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be placed in the log book for maintaining the blood glu-
cose and insulin records; also, separate instructions will
be given to the e-device (fit bit) groups about charging
the device daily at night and wearing it during the day.
Study participants/parents will be sent e-messages as re-
minders for maintaining log books and/or step count.
Mobile messages will be sent by trained staff on a daily
basis to the assigned groups of patients. Log book data
will be obtained every 3 months during doctor visits or
through e-messages.
Outcome measures
The major outcome variable is HbA1c, measured at
baseline and 3 and 6 months. HbA1C will be compared
with the control (routine) group and with the other
groups in this factorial design. This will also be com-
pared within one group: baseline to 3 months and base-
line to 6 months. We will explore between-group
variation and within-group variation and any interac-
tions between the groups over time.
In addition, secondary outcome variables will be num-
ber of all hypoglycemic episodes (blood glucose < 70
mg/dL (3.9 mmol/L) and ketoacidosis episodes (hyper-
glycemia blood glucose > 11 mmol/L, venous pH < 7.3,
or serum bicarbonate < 15 mmol/L, ketonemia blood ß-
hydroxybuyrate ≥ 3 mmol/L), taken as a composite
variable at baseline and 3 and 6 months [30–32]. Total
number of abnormal episodes counted over the follow-
up period will be considered as a composite outcome.
Data collection tools
At baseline we will determine the socio-demographic
profile of patients, along with user satisfaction of main-
taining log books and using the e-device for measuring
step count. Additionally, clinical information for T1D
and other co-morbidities, including age of onset, dur-
ation, complications, hospitalizations, habits for man-
aging T1D, and other lifestyle characteristics, will be
ascertained.
Two other tools will supplement data collection at
baseline (0 months) and 3- and 6-month visits; namely,
a 24-hour dietary recall [33] and physical activity assess-
ment using both the International Physical Activity
Questionnaire (IPAQ) and Youth Physical Activity
Questionnaire (YPAQ) [34] (Table 2). The designed
questionnaires and tools will be modified for clarity and
cultural relevance after pilot testing on at least five T1D
patients prior to initiation of the study. All groups will
be followed up overall for a total period of 6 months.
During these 6 months data for any additional clinic/
hospital visit will be obtained from the medical record
files of participants.
Table 1 Mobile messages by group
E-MESSEGES FOR GROUP C E-MESSEGES FOR GROUP D
Remember to check your blood sugars before every meal and record it
in your logbook. Keep up the good work.
How many steps have you taken today? Make sure your fitbit is charged
to record all that hard work!
Good luck and have a healthy day
Don’t forget to check and record your blood sugar and insulin dose in
your logbook. This record will help you to discuss it with your doctor and
make your sugar levels near to the targets.
Have a good day!
Recording your step count can help you to manage your blood sugar, so
Fitbit is here to help you to count your steps daily. Don’t forget to charge
it. Have a good day!
Keeping an eye on your blood sugar. Knowing this can help you and
your doctor to adjust your food choices and insulin doses accordingly.
Thanks for checking and recording it in your log book!
Remember! Any type of physical activity you do will help you lower your
blood glucose! It’s time to go for a walk and increase your daily steps.
Fitbit is here to count your every step so don’t forget to note your steps
daily in your logbook.
Thank you for all your hard work!
Self-testing of your blood sugar is an important tool in managing your
treatment plan and preventing diabetes complications, so try to keep
your blood sugar levels record in your logbook as suggested by your
physician and help yourself and your doctor to manage your treatment
accordingly.
Fitbit is with you to count your steps during housework, outdoor work,
job activities, recreational activities, and exercise. So charge you fitbit as
required and don’t forget to record your steps daily in logbook. Thanks
Self-monitoring of blood sugar levels provides useful information for
diabetes management as it can help you reach your overall treatment
goals. So keep checking and recording it in your logbook. Good day!
Improved fitness lowers your blood glucose level, relieves stress, helps
insulin work better and strengthens the heart, muscles, and bones. It’s
time to set your goals and make your life healthier. Wear your fitbit
device all the day and record your steps in log book. Don’t forget to
charge it.
Stay Healthy!
It is time to check your blood sugar levels and don’t forget to keep
recording of your sugar levels and insulin dose in you logbook. Thanks
for your all efforts.
If you sit for long hours at work or at home, try to get up once every
hour and take a quick walk around the room. Walking is a great way to
get fit! So use your fitbit and record all the steps you have taken in the
log book. Thanks you for your Hard work!
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Ethical considerations
Study participants will be asked to provide informed,
written assent/consent prior to participation in this
study. Appropriate assent/consent will be obtained by
trained data collectors during face to face interviews; the
data collectors will also make contact via phone call.
Confidentiality of participants will be maintained
throughout the follow-up. Study participants will be
interviewed in areas separate to the clinical examination
room and identification codes will be used to manage
the data. This study will not impose any risk or discom-
fort on any patient or their parents, except for requiring
their valuable time; however, this study intends to intro-
duce beneficial lifestyle changes for improving the man-
agement of T1D by young adolescents and adults. Ethics
approval from Aga Khan University Ethical Review
Committee (AKU-ERC) was provided prior to initiating
this study.
Data management
Data collection will be done using digital forms. For any
missing or inappropriate information the participant will
be contacted on their cell phone number for correction
and verification. Every effort will be made to complete
the information. All study data will be stored on a pro-
tected central server at AKU. Only assigned members of
the internal study team can access the respective files.
Data analysis
We will use an intention-to-treat (ITT) analysis to evalu-
ate changes in HbA1C and abnormal episodes of
hypoglycemia and ketoacidosis. Generalized estimating
equations will be used, with HbA1C readings at different
points in time as our outcome variable. The mean
change in HbA1C due to interventions will be estimated
at 3 and 6 months, controlling for socio-demographic,
clinical, nutritional, and physical activity variables. Sec-
ondary outcome variables are reported episodes of acute
complications like hypoglycemia and diabetic ketoacido-
sis and will be recorded from interview-based data con-
ducted at baseline and 3 and 6 months. In addition,
these episodes will be further counted for the follow-up
period using the daily log book of each participant.
Negative binomial regression will be used to observe
the relationship among the four groups and number of
episodes, adjusting for any socio-demographic, clinical,
nutrition, and physical activity-related variables. If there
is an excess number of ‘zeros’—meaning no abnormal
episodes—then zero inflated negative binomial regres-
sion will be used instead of ordinary negative binomial
regression. Twenty-four-hour dietary recall will be con-
verted into total number of calories and percentage
carbohydrate intake. Nutrition will be explored for total
calories and food groups using factor analysis. Physical
activity will be measured using step count data logged
on a daily basis. These step counts will be used as time-
dependent covariates for the final model. Step counts
logged on a daily basis in two groups over a period of 6
months will be obtained from log books. The distribu-
tion of these data will be checked and, if needed, will be
transformed. Changes in dietary habits and in step count
over time will be used as a covariate in the final model.
Physical activities reported during the three interviews
will be converted into hours per week and categorized
by type of activity as mild, moderate, and severe
exercise.
In addition, we will explore blood glucose variability
on a daily basis to calculate the average daily risk range
for hypoglycemia using the standard method developed
Table 2 Assessments that will be carried out in the study and data collection time points (baseline, 3 months, and 6 months)







Age, Sex, Weight, Height, Marital Status, Education, Occupation and Parents




History of Diabetes and History if comorbidities ✓
Episodes of complications, any hospital admission, Frequency of self-monitoring




Frequency of visit to diabetic clinic, frequency of visit to dietitian ✓ ✓ ✓
Daily Physical
activity of 1 week
Questionnaire adapted from IPAQ and YPAQ ✓ ✓ ✓
Barriers to physical
activity
Questionnaire adapted from IPAQ and YPAQ ✓ ✓ ✓
Dietary Intake Self-Reported 24- Hour Dietary Recall Questionnaire ✓ ✓ ✓
Biochemical
measures
Pathology HbA1C ✓ ✓ ✓
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by Kovatchev and modified for relevant use by other in-
vestigators [15, 16].
Discussion
This randomized controlled trial tests the hypothesis
that log book maintenance for SMBG will substantially
increase among individuals receiving e-message re-
minders and will provide evidence for significant correl-
ation between daily step count and blood glucose levels
and overall changes in HbA1c in T1D patients. We fur-
ther expect an interactive effect of e-message reminders
and daily step count on blood glucose levels. Such inter-
ventions are necessary to bring about positive life style
changes among T1D patients. Non-pharmacological in-
terventions like these are user friendly, engaging patients
with their home-based care and integrating them with
health-care services. A multipronged approach is re-
quired to manage diabetes and reduce the severity of
complications and our simple interventions include food
diaries and physical activity logs together with managing
blood sugar by insulin therapy [12, 13, 17, 20, 28].
There is reported evidence of a positive association of
e-device with lifestyle changes and diabetes. Most life-
style intervention studies using an e-device have been fo-
cused mainly on education related to advice on diet and
physical activity for T2DM, but very few studies have fo-
cused on T1D and our study may add further evidence
with regard to it [22–27]. Dissemination of this study
will provide a potential tool in the form of a log book to
be used by practicing physicians in low-resource set-
tings. Additionally, the evidence generated from this
study will be shared at various fora to help physicians or
providers choose the most suitable lifestyle program for
their T1D patients.
Trial status
This is protocol version 1.0 (June 1, 2018). Recruitment
began on October 29, 2018 and recruitment will be
completed on approximately March 31, 2020.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13063-020-4205-7.
Additional file 1. SPIRIT 2013 checklist: Recommended items to address
in a clinical trial protocol and related documents.
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